Walgreens Boots Alliance, Inc. (WBA) EPS Estimated At $1.55

March 14, 2018 - By Linda Rogers

 Walgreens Boots Alliance, Inc. (WBA) EPS Estimated At $1.55

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54B giving it 11.06 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock decreased 1.88% or $1.31 during the last trading session, reaching $68.55. About 4.29M shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 15, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Outperform” rating given on Monday, July 18 by Credit Suisse. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) earned “Buy” rating by RBC Capital Markets on Wednesday, October 28. The rating was maintained by Credit Suisse on Thursday, September 1 with “Outperform”. Barclays Capital reinitiated it with “Equal-Weight” rating and $76 target in Thursday, March 10 report. SunTrust maintained the shares of WBA in report on Wednesday, December 20 with “Hold” rating. The firm has “Buy” rating given on Tuesday, June 7 by Bank of America. Robert W. Baird maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) rating on Thursday, October 19. Robert W. Baird has “Outperform” rating and $80 target. As per Friday, September 8, the company rating was maintained by Needham. The rating was maintained by UBS on Wednesday, August 23 with “Buy”. Leerink Swann maintained it with “Buy” rating and $8600 target in Thursday, July 20 report.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $67.91 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.91 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More notable recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: Seekingalpha.com which released: “Walgreens Boots Alliance appoints James Kehoe Global CFO” on March 08, 2018, also Zacks.com with their article: “Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?” published on February 27, 2018, Seekingalpha.com published: “Walgreens Boots Alliance – What Keeps The Stock From Going Up?” on March 12, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were released by: Nasdaq.com and their article: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for February …” published on February 13, 2018 as well as Businesswire.com‘s news article titled: “Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots …” with publication date: March 05, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.